SEC 13F Intelligence

Roumell Asset Management, LLC / ETON

Roumell Asset Management, LLC’s Eton Pharmaceuticals Inc Position

Does Roumell Asset Management, LLC own Eton Pharmaceuticals Inc (ETON)? Not currently — the last reported position was 449.4K shares worth $1M in Q4 2022; the fund’s latest 13F (Q2 2024) no longer reports it.

Position Value
$1M
Q4 2022
Shares
449.4K
% of Portfolio
+3.12%
Quarters Held
5
position exited

Position History ETON

Reported value by quarter
Q4 ’21: $2MQ4 ’21Q1 ’22: $2MQ1 ’22Q2 ’22: $1MQ2 ’22Q3 ’22: $944,000Q3 ’22Q4 ’22: $1MQ4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2022449.4K$1M+3.12%
Q3 2022449.4K$944,000+2.04%
Q2 2022449.4K$1M+2.29%
Q1 2022449.4K$2M+3.17%
Q4 2021449.4K$2M+2.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Roumell Asset Management, LLC’s full portfolio or all institutional holders of ETON.